The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $12,736,764 in first-year total cost, median $783,651.
Most frequent study sections
- Cellular and Molecular Biology of Glia Study Section[CMBG]3
- Molecular Neurogenetics Study Section[MNG]2
- Special Emphasis Panel[ZRG1 MDCN-E (03)]2
- Genetics of Health and Disease Study Section[GHD]1
- Special Emphasis Panel[ZRG1 MDCN-P (56)]1
Most frequent institutions
- EMORY UNIVERSITY1
- ENDEAVOR HEALTH CLINICAL OPERATIONS1
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- MASSACHUSETTS GENERAL HOSPITAL1
- NEW YORK STEM CELL FOUNDATION1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Modeling the impact of regulatory and splicing variants on cellular function in Alzheimer's disease1RF1AG065926-01A1 | BRENNAND, KRISTEN JENNIFERRAJ, TOWFIQUE | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $2,360,820 | MNG |
| 2020 | Study of cell-type specific Alzheimer's disease genetic variants using a novel bioengineered model of iPSC-derived neural tissue1R01AG061838-01A1 | HAYDON, PHILIP GKAPLAN, DAVID L.TESCO, GIUSEPPINA | TUFTS UNIVERSITY BOSTON, MA | $975,889 | ZRG1 |
| 2020 | Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models1R01AG065611-01A1 | LI, BINGSHANWEN, ZHEXING | EMORY UNIVERSITY, GA | $787,568 | MNG |
| 2020 | Identifying Alzheimer’s Disease Causal Variants and Target Genes Using iPSC-derived Microglia1R01AG066871-01 | COHEN, TODD JONATHANPHANSTIEL, DOUGLAS H.WON, HYEJUNG | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $758,870 | GHD |
| 2019 | Understanding the functional impact of cumulative genetic risk in Alzheimer Disease1RF1AG063540-01 | GARDEN, GWENN AJAYADEV, SUMAN | UNIVERSITY OF WASHINGTON, WA | $4,186,727 | ZRG1 |
| 2019 | Modeling Alzheimer's disease genetic variants in hiPSC1R01AG063175-01 | DUAN, JUBAOTHINAKARAN, GOPAL | ENDEAVOR HEALTH CLINICAL OPERATIONS, IL | $779,733 | ZRG1 |
| 2019 | The impact of AD-associated genetic variants in 3D human mixed neural-glial models of AD1R01AG061891-01A1 | KIM, DOO YEONTANZI, RUDOLPH EMILE | MASSACHUSETTS GENERAL HOSPITAL, MA | $749,200 | CMBG |
| 2018 | A chemical chaperomics platform for AD1R56AG061869-01 | CHIOSIS, GABRIELA | SLOAN-KETTERING INST CAN RESEARCH, NY | $904,900 | ZRG1 |
| 2018 | Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease1R01AG061894-01 | FOSSATI, VALENTINAGANDY, SAMUEL E.NOGGLE, SCOTT ALLEN | NEW YORK STEM CELL FOUNDATION, NY | $641,748 | CMBG |
| 2018 | Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease1R01AG061895-01 | DAVTYAN, HAYK | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $591,309 | CMBG |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.